Bisphosphonates: Preventing Bone Loss in Multiple Myeloma
Multiple Myeloma is a form of cancer that poses the risk of severe bone loss. To combat this, healthcare professionals often prescribe Bisphosphonates, a group of medications including Aredia or Zometa. These drugs are specifically designed to prevent or slow down bone loss in patients with Multiple Myeloma. Although Bisphosphonates cannot reverse bone loss, their primary objective is to prevent any further deterioration.
During Multiple Myeloma treatment, patients may experience additional bone loss, which is often accompanied by significant weight loss. To counter this, doctors may recommend a specific diet plan aimed at helping patients regain lost weight.
Supplementation
Managing nutritional deficiencies is crucial for individuals with Multiple Myeloma. Supplementation plays a vital role in maintaining the overall strength of the body, particularly during cancer treatment, even in advanced stages. Anemia is a common condition experienced by many Multiple Myeloma patients. To combat anemia, iron supplements can be beneficial. Additionally, supplements such as Folic Acid, Vitamin B-1, Vitamin B-2, Vitamin B-6, and Vitamin B-12 can aid in increasing red blood cells. These supplements also support the immune system and the nervous system.